首页 > 最新文献

Taiwan Journal of Ophthalmology最新文献

英文 中文
Dr. Google will see you now: But will he make you sick? 谷歌医生现在会给你看病:但他会让你生病吗?
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-08-03 eCollection Date: 2024-07-01 DOI: 10.4103/tjo.TJO-D-23-00047
Ivan Goldberg

Advances in technology have empowered patients to seek health information and to self-diagnose online. They do so, increasingly. Instead of shying away from patients' online-gained health information, clinicians can use it to fuel discussion, answer their questions, and, thereby, reinforce the all-important doctor-patient therapeutic alliance. Through patient-centered communication, clinicians can increase patient trust and generate better health outcomes.

技术的进步赋予了患者在网上寻求健康信息和自我诊断的能力。他们越来越多地这样做。临床医生不应该回避患者在网上获取的健康信息,而是可以利用这些信息来促进讨论,回答他们的问题,从而加强至关重要的医患治疗联盟。通过以患者为中心的沟通,临床医生可以提高患者的信任度,取得更好的医疗效果。
{"title":"Dr. Google will see you now: But will he make you sick?","authors":"Ivan Goldberg","doi":"10.4103/tjo.TJO-D-23-00047","DOIUrl":"10.4103/tjo.TJO-D-23-00047","url":null,"abstract":"<p><p>Advances in technology have empowered patients to seek health information and to self-diagnose online. They do so, increasingly. Instead of shying away from patients' online-gained health information, clinicians can use it to fuel discussion, answer their questions, and, thereby, reinforce the all-important doctor-patient therapeutic alliance. Through patient-centered communication, clinicians can increase patient trust and generate better health outcomes.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"14 3","pages":"371-375"},"PeriodicalIF":1.0,"publicationDate":"2023-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Big data to guide glaucoma treatment. 大数据指导青光眼治疗。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-07-28 eCollection Date: 2024-07-01 DOI: 10.4103/tjo.TJO-D-23-00068
Jo-Hsuan Wu, Shan Lin, Sasan Moghimi

Ophthalmology has been at the forefront of the medical application of big data. Often harnessed with a machine learning approach, big data has demonstrated potential to transform ophthalmic care, as evidenced by prior success on clinical tasks such as the screening of ophthalmic diseases and lesions via retinal images. With the recent establishment of various large ophthalmic datasets, there has been greater interest in determining whether the benefits of big data may extend to the downstream process of ophthalmic disease management. An area of substantial investigation has been the use of big data to help guide or streamline management of glaucoma, which remains a leading cause of irreversible blindness worldwide. In this review, we summarize relevant studies utilizing big data and discuss the application of the findings in the risk assessment and treatment of glaucoma.

眼科一直处于大数据医疗应用的前沿。大数据通常采用机器学习方法,在临床任务(如通过视网膜图像筛查眼科疾病和病变)中取得的成功证明了大数据具有改变眼科护理的潜力。最近,随着各种大型眼科数据集的建立,人们对确定大数据的优势是否可以扩展到眼科疾病管理的下游流程产生了更大的兴趣。利用大数据帮助指导或简化青光眼的管理是一项重要的研究领域,青光眼仍然是导致全球不可逆失明的主要原因。在这篇综述中,我们总结了利用大数据进行的相关研究,并讨论了研究结果在青光眼风险评估和治疗中的应用。
{"title":"Big data to guide glaucoma treatment.","authors":"Jo-Hsuan Wu, Shan Lin, Sasan Moghimi","doi":"10.4103/tjo.TJO-D-23-00068","DOIUrl":"10.4103/tjo.TJO-D-23-00068","url":null,"abstract":"<p><p>Ophthalmology has been at the forefront of the medical application of big data. Often harnessed with a machine learning approach, big data has demonstrated potential to transform ophthalmic care, as evidenced by prior success on clinical tasks such as the screening of ophthalmic diseases and lesions via retinal images. With the recent establishment of various large ophthalmic datasets, there has been greater interest in determining whether the benefits of big data may extend to the downstream process of ophthalmic disease management. An area of substantial investigation has been the use of big data to help guide or streamline management of glaucoma, which remains a leading cause of irreversible blindness worldwide. In this review, we summarize relevant studies utilizing big data and discuss the application of the findings in the risk assessment and treatment of glaucoma.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"14 3","pages":"333-339"},"PeriodicalIF":1.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetics of the anterior segment dysgenesis. 前节发育不良的遗传学。
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-07-18 eCollection Date: 2023-10-01 DOI: 10.4103/tjo.TJO-D-23-00062
Diego I Paredes, Jenina E Capasso, Celeste S Wyman, Alex V Levin

The anterior segment dysgeneses are a broad group of heterogeneous disorders characterized by developmental abnormalities of the anterior segment of the eye, including primary congenital aphakia, Peters sequence, aniridia, and Axenfeld-Rieger spectrum. These conditions can have overlapping phenotypes and both genotypic and phenotypic heterogeneity. This article provides a strategy for both phenotyping and then genotyping using a targeted stepwise approach.

前节发育异常是一大类以眼球前节发育异常为特征的异质性疾病,包括原发性先天性无晶体眼、彼得斯序列、无晶体眼和阿森费尔德-里格谱系。这些病症可能有重叠的表型以及基因型和表型异质性。本文提供了一种先进行表型分析,然后采用有针对性的逐步方法进行基因分型的策略。
{"title":"Genetics of the anterior segment dysgenesis.","authors":"Diego I Paredes, Jenina E Capasso, Celeste S Wyman, Alex V Levin","doi":"10.4103/tjo.TJO-D-23-00062","DOIUrl":"10.4103/tjo.TJO-D-23-00062","url":null,"abstract":"<p><p>The anterior segment dysgeneses are a broad group of heterogeneous disorders characterized by developmental abnormalities of the anterior segment of the eye, including primary congenital aphakia, Peters sequence, aniridia, and Axenfeld-Rieger spectrum. These conditions can have overlapping phenotypes and both genotypic and phenotypic heterogeneity. This article provides a strategy for both phenotyping and then genotyping using a targeted stepwise approach.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 4","pages":"500-504"},"PeriodicalIF":1.1,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients. 台湾地区2型黄斑毛细血管扩张症的临床特征及分期系统比较
IF 1.1 Q4 OPHTHALMOLOGY Pub Date : 2023-06-16 eCollection Date: 2023-07-01 DOI: 10.4103/tjo.TJO-D-22-00154
Yan-Yu Chen, Yi-Ling Chen, Jian-Sheng Wu, San-Ni Chen

Purpose: The purpose of this study is to report the clinical characteristics of macular telangiectasia type 2 (MacTel 2) in Taiwan.

Materials and methods: Retrospective analysis of patients diagnosed with MacTel 2 over a 7-year period in Changhua Christian Hospital. Best-corrected visual acuity (BCVA), fundus photography, fluorescein angiography, optical coherence tomography (OCT), and OCT angiography (OCTA) images were reviewed. Differences in BCVA and central macular thickness (CMT) were compared between the initial/baseline and final visits. The staging was performed according to the Gass and Blodi classification and OCTA.

Results: There were 38 eyes in 19 patients were collected (Male: Female = 5:14). The mean age at diagnosis was 65.90 ± 8.26 years and the follow-up duration was 39.26 ± 28.31 months. All patients had both eyes affected, and eight of the 19 patients had a history of diabetes mellitus (DM). The mean initial logarithm of the minimum angle of resolution (logMAR) BCVA was 0.40 ± 0.31 and the mean final logMAR BCVA was 0.61 ± 0.53. Difference of BCVA equal or more than two lines between both eyes was noted in 63.1% (12 of 19) of patients at the initial visit and in 78.9% (15 of 19) of patients at the final follow-up. The mean CMT was 224.42 ± 38.50 μm at baseline and 222.05 ± 40.27 μm at the final visit. OCT illustrated macular hole in three eyes of three patients. At the final follow-up, retinal-choroidal anastomosis was noted in 17 eyes. Subretinal neovascularization (SRNV) was not present in any eye.

Conclusion: Bilateral involvement, asymmetrical BCVA in both eyes, low incidence of SRNV, and high prevalence of DM were characteristics of patients of MacTel 2 in Taiwan.

目的:报告台湾地区2型黄斑毛细血管扩张症(MacTel2)的临床特点。材料和方法:回顾性分析彰化基督教医院7年来诊断为MacTel 2的患者。对最佳矫正视力(BCVA)、眼底摄影、荧光素血管造影、光学相干断层扫描(OCT)和OCT血管造影(OCTA)图像进行了回顾。比较初次/基线访视和最终访视之间BCVA和中央黄斑厚度(CMT)的差异。根据Gass和Blodi分类以及OCTA进行分期。结果:19例患者共38眼(男:女=5:14)。诊断时的平均年龄为65.90±8.26岁,随访时间为39.26±28.31个月。所有患者的双眼都受到影响,19名患者中有8名有糖尿病(DM)病史。最小分辨角(logMAR)BCVA的平均初始对数为0.40±0.31,平均最终logMAR BCVA为0.61±0.53。63.1%(12/19)的患者在初次就诊时和78.9%(15/19)的病人在最终随访时发现双眼BCVA差异等于或大于两条线。基线时的平均CMT为224.42±38.50μm,最后一次就诊时为222.05±40.27μm。OCT显示三名患者的三只眼睛出现黄斑裂孔。在最后的随访中,17只眼睛的视网膜-脉络膜吻合。视网膜下新生血管(SRNV)在任何一只眼睛中都不存在。结论:台湾MacTel 2患者双侧受累、双眼BCVA不对称、SRNV发病率低、DM患病率高是其特征。
{"title":"Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients.","authors":"Yan-Yu Chen, Yi-Ling Chen, Jian-Sheng Wu, San-Ni Chen","doi":"10.4103/tjo.TJO-D-22-00154","DOIUrl":"10.4103/tjo.TJO-D-22-00154","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study is to report the clinical characteristics of macular telangiectasia type 2 (MacTel 2) in Taiwan.</p><p><strong>Materials and methods: </strong>Retrospective analysis of patients diagnosed with MacTel 2 over a 7-year period in Changhua Christian Hospital. Best-corrected visual acuity (BCVA), fundus photography, fluorescein angiography, optical coherence tomography (OCT), and OCT angiography (OCTA) images were reviewed. Differences in BCVA and central macular thickness (CMT) were compared between the initial/baseline and final visits. The staging was performed according to the Gass and Blodi classification and OCTA.</p><p><strong>Results: </strong>There were 38 eyes in 19 patients were collected (Male: Female = 5:14). The mean age at diagnosis was 65.90 ± 8.26 years and the follow-up duration was 39.26 ± 28.31 months. All patients had both eyes affected, and eight of the 19 patients had a history of diabetes mellitus (DM). The mean initial logarithm of the minimum angle of resolution (logMAR) BCVA was 0.40 ± 0.31 and the mean final logMAR BCVA was 0.61 ± 0.53. Difference of BCVA equal or more than two lines between both eyes was noted in 63.1% (12 of 19) of patients at the initial visit and in 78.9% (15 of 19) of patients at the final follow-up. The mean CMT was 224.42 ± 38.50 μm at baseline and 222.05 ± 40.27 μm at the final visit. OCT illustrated macular hole in three eyes of three patients. At the final follow-up, retinal-choroidal anastomosis was noted in 17 eyes. Subretinal neovascularization (SRNV) was not present in any eye.</p><p><strong>Conclusion: </strong>Bilateral involvement, asymmetrical BCVA in both eyes, low incidence of SRNV, and high prevalence of DM were characteristics of patients of MacTel 2 in Taiwan.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 1","pages":"346-352"},"PeriodicalIF":1.1,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47371960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author reply: Intricate clinical evaluation and management strategies in vision-threatening phacomorphic glaucoma. 作者回复:威胁视力的青光眼复杂的临床评估和管理策略。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-06-13 eCollection Date: 2023-04-01 DOI: 10.4103/tjo.TJO-D-22-00068
Richa Gupta, Lokesh Chauhan
{"title":"Author reply: Intricate clinical evaluation and management strategies in vision-threatening phacomorphic glaucoma.","authors":"Richa Gupta, Lokesh Chauhan","doi":"10.4103/tjo.TJO-D-22-00068","DOIUrl":"10.4103/tjo.TJO-D-22-00068","url":null,"abstract":"","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"261-262"},"PeriodicalIF":1.0,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/74/bc/TJO-13-261.PMC10361425.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonsurgical management of upper eyelid retraction in thyroid eye disease. 甲状腺性眼病上睑挛缩的非手术治疗。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-23 eCollection Date: 2024-10-01 DOI: 10.4103/tjo.TJO-D-23-00043
Stephanie Ming Young, Yoon-Duck Kim, Kyung In Woo

Upper eyelid retraction (UER) is the most common sign of thyroid eye disease (TED) and may result in lagophthalmos and exposure keratopathy. Measures to address UER are varied and include conservative treatment, surgical intervention, and injections of botulinum toxin, hyaluronic acid (HA) filler, and triamcinolone acetonide (TA). Our article will discuss the various nonsurgical aspects of managing TED-related UER, focusing on the injections of botulinum toxin, HA filler, and TA to the upper eyelid, which have all been reported to be effective in improving UER in both active and inactive states of TED. Individual response may vary, and repeated injections may be necessary.

上睑挛缩(UER)是甲状腺眼病(TED)最常见的症状,可能导致眼lageye和暴露性角膜病变。解决UER的措施多种多样,包括保守治疗、手术干预、注射肉毒杆菌毒素、透明质酸(HA)填充剂和曲安奈德(TA)。我们的文章将讨论处理TED相关UER的各种非手术方面,重点是在上眼睑注射肉毒杆菌毒素、透明质酸填充物和TA,这些都被报道在TED活跃和不活跃状态下有效改善UER。个体反应可能不同,可能需要重复注射。
{"title":"Nonsurgical management of upper eyelid retraction in thyroid eye disease.","authors":"Stephanie Ming Young, Yoon-Duck Kim, Kyung In Woo","doi":"10.4103/tjo.TJO-D-23-00043","DOIUrl":"10.4103/tjo.TJO-D-23-00043","url":null,"abstract":"<p><p>Upper eyelid retraction (UER) is the most common sign of thyroid eye disease (TED) and may result in lagophthalmos and exposure keratopathy. Measures to address UER are varied and include conservative treatment, surgical intervention, and injections of botulinum toxin, hyaluronic acid (HA) filler, and triamcinolone acetonide (TA). Our article will discuss the various nonsurgical aspects of managing TED-related UER, focusing on the injections of botulinum toxin, HA filler, and TA to the upper eyelid, which have all been reported to be effective in improving UER in both active and inactive states of TED. Individual response may vary, and repeated injections may be necessary.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"548-553"},"PeriodicalIF":1.0,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of changes in number of hyperreflective dots after intravitreal ranibizumab or dexamethasone implant in patients with branch retinal vein occlusion. 比较视网膜分支静脉闭塞患者静脉内注射雷尼珠单抗或地塞米松后超反射点数量的变化。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-23 eCollection Date: 2024-07-01 DOI: 10.4103/tjo.TJO-D-22-00177
Aylin Karalezli, Sema Tamer Kaderli, Ahmet Kaderli, Cansu Kaya, Sabahattin Sul

Purpose: To compare the effect of intravitreal ranibizumab (IVR) or intravitreal dexamethasone implants (IVD) on the regression of hyperreflective dots (HRDs) in patients with branch retinal vein occlusion (BRVO).

Materials and methods: Thirty-seven eyes with cystoid macular edema who received IVR or IVD and followed up for at least 12 months were included in this study. The patients were divided into three Groups according to intravitreal treatments. Group 1 consisted of 12 eyes who received only IVD, Group 2 consisted of 10 eyes who received only IVR, and Group 3 consisted of 15 eyes who received both IVD and IVR. The number of HRDs and best-corrected visual acuity (BCVA) were compared between the Groups through the follow-up time.

Results: The mean number of HRDs in inner and outer retinal layers was significantly decreased in Group 1 and Group 3 (For Group 1; P < 0.001, P = 0.001, for Group 3; P < 0.001, P < 0.001). At the 1st year, the number of HRDs in inner and outer retinal layers was significantly lower in Group 1 and Group 3 than Group 2 (All P < 0.05). The BCVA was higher in Group 3 than Group 2 at 1st year (P = 0.048).

Conclusion: The HRDs should be considered inflammatory markers in the follow-up of CME in BRVO.

目的:比较玻璃体内雷尼珠单抗(IVR)或玻璃体内地塞米松植入剂(IVD)对视网膜分支静脉闭塞(BRVO)患者高反光点(HRDs)消退的影响:本研究共纳入 37 例囊样黄斑水肿患者,他们均接受了 IVR 或 IVD 治疗,并随访了至少 12 个月。根据玻璃体内治疗方法的不同,患者被分为三组。第一组有 12 只眼睛只接受了 IVD 治疗,第二组有 10 只眼睛只接受了 IVR 治疗,第三组有 15 只眼睛同时接受了 IVD 和 IVR 治疗。在随访期间,比较了各组的 HRDs 数量和最佳矫正视力(BCVA):结果:第1组和第3组视网膜内外层HRD的平均数量明显减少(第1组:P < 0.001,P = 0.001;第3组:P < 0.001,P < 0.001)。第一年时,第 1 组和第 3 组视网膜内层和外层的 HRD 数量明显低于第 2 组(均 P <0.05)。第 1 年时,第 3 组的 BCVA 高于第 2 组(P = 0.048):结论:HRDs应被视为BRVO患者CME随访中的炎症标志物。
{"title":"Comparison of changes in number of hyperreflective dots after intravitreal ranibizumab or dexamethasone implant in patients with branch retinal vein occlusion.","authors":"Aylin Karalezli, Sema Tamer Kaderli, Ahmet Kaderli, Cansu Kaya, Sabahattin Sul","doi":"10.4103/tjo.TJO-D-22-00177","DOIUrl":"10.4103/tjo.TJO-D-22-00177","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the effect of intravitreal ranibizumab (IVR) or intravitreal dexamethasone implants (IVD) on the regression of hyperreflective dots (HRDs) in patients with branch retinal vein occlusion (BRVO).</p><p><strong>Materials and methods: </strong>Thirty-seven eyes with cystoid macular edema who received IVR or IVD and followed up for at least 12 months were included in this study. The patients were divided into three Groups according to intravitreal treatments. Group 1 consisted of 12 eyes who received only IVD, Group 2 consisted of 10 eyes who received only IVR, and Group 3 consisted of 15 eyes who received both IVD and IVR. The number of HRDs and best-corrected visual acuity (BCVA) were compared between the Groups through the follow-up time.</p><p><strong>Results: </strong>The mean number of HRDs in inner and outer retinal layers was significantly decreased in Group 1 and Group 3 (For Group 1; <i>P</i> < 0.001, <i>P</i> = 0.001, for Group 3; <i>P</i> < 0.001, <i>P</i> < 0.001). At the 1<sup>st</sup> year, the number of HRDs in inner and outer retinal layers was significantly lower in Group 1 and Group 3 than Group 2 (All <i>P</i> < 0.05). The BCVA was higher in Group 3 than Group 2 at 1<sup>st</sup> year (<i>P</i> = 0.048).</p><p><strong>Conclusion: </strong>The HRDs should be considered inflammatory markers in the follow-up of CME in BRVO.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"14 3","pages":"387-393"},"PeriodicalIF":1.0,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pupillary dynamics and accommodative response in mild traumatic brain injury. 轻度脑外伤的瞳孔动态和适应反应。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-23 eCollection Date: 2024-04-01 DOI: 10.4103/tjo.TJO-D-22-00169
Pritam Dutta, Ayisha Atiya, Smita Vittal, S Ambika, Jameel Rizwana Hussaindeen

Purpose: To measure the pupillary dynamics and accommodative response in individuals with mild traumatic brain injury (mTBI) as compared to age-matched controls.

Materials and methods: This prospective comparative study was carried out at the neuro-optometry clinic of a tertiary eye care hospital. Sixty-three subjects with a history of mTBI and ninety age-matched controls were enrolled in this study. Subjects in the age range of 18-35 years were included in the study. A comprehensive neuro-optometric assessment was performed followed by pupillary dynamics and accommodation response measurements using NeurOptics® pupillary light reflex™-3000 and Grand-Seiko WAM-5500 binocular accommodation auto ref/keratometer | shigiya machinery works LTD.

Results: A statistically significant difference was noticed for constriction percentage (%): 32.73 ± 9.20 versus 39.93 ± 7.36 (P < 0.001), average constriction velocity (mm/s): 2.24 ± 0.85 versus 2.62 ± 0.68 (P = 0.002), maximum constriction velocity (mm/s): 3.82 ± 1.33 versus 4.42 ± 0.93 (P = 0.004) and T75 (recovery period to 75% of the baseline pupillary diameter in sec): 1.38 ± 0.36 versus 2.0 ± 0.82 (P < 0.001) in mTBI compared to age-matched controls. A statistically significant difference was noted for accommodative response (in D) as well as in the sample as compared to age-matched controls: -1.12 ± 0.64 versus - 1.39 ± 0.47 (P < 0.001).

Conclusion: Pupillary constriction velocities and accommodative response are significantly affected in mTBI. These findings have important clinical implications in being able to understand the visual symptoms following an mTBI.

目的:与年龄匹配的对照组相比,测量轻度脑外伤(mTBI)患者的瞳孔动态和适应反应:这项前瞻性比较研究在一家三级眼科医院的神经视光诊所进行。研究共招募了 63 名有 mTBI 病史的受试者和 90 名年龄匹配的对照组受试者。研究对象的年龄在 18-35 岁之间。研究人员使用 NeurOptics® pupillary light reflex™-3000 和 Grand-Seiko WAM-5500 双目调节自动反射/角膜计进行了全面的神经视力评估,随后使用 NeurOptics® pupillary light reflex™-3000 和 Grand-Seiko WAM-5500 双目调节自动反射/角膜计测量了瞳孔动态和调节反应:收缩百分比(%)的差异具有统计学意义:3.82 ± 1.33 对 4.42 ± 0.93(P = 0.004),T75(恢复到基线瞳孔直径 75% 的时间,秒):与年龄匹配的对照组相比,mTBI患者的T75(恢复到基线瞳孔直径75%的时间,以秒为单位):1.38 ± 0.36对2.0 ± 0.82(P < 0.001)。与年龄匹配的对照组相比,适应反应(以 D 为单位)以及样本中的适应反应均存在明显的统计学差异:-1.12 ± 0.64 对 - 1.39 ± 0.47(P < 0.001):结论:瞳孔收缩速度和适应反应在 mTBI 中受到显著影响。这些发现对理解 mTBI 后的视觉症状具有重要的临床意义。
{"title":"Pupillary dynamics and accommodative response in mild traumatic brain injury.","authors":"Pritam Dutta, Ayisha Atiya, Smita Vittal, S Ambika, Jameel Rizwana Hussaindeen","doi":"10.4103/tjo.TJO-D-22-00169","DOIUrl":"10.4103/tjo.TJO-D-22-00169","url":null,"abstract":"<p><strong>Purpose: </strong>To measure the pupillary dynamics and accommodative response in individuals with mild traumatic brain injury (mTBI) as compared to age-matched controls.</p><p><strong>Materials and methods: </strong>This prospective comparative study was carried out at the neuro-optometry clinic of a tertiary eye care hospital. Sixty-three subjects with a history of mTBI and ninety age-matched controls were enrolled in this study. Subjects in the age range of 18-35 years were included in the study. A comprehensive neuro-optometric assessment was performed followed by pupillary dynamics and accommodation response measurements using NeurOptics® pupillary light reflex™-3000 and Grand-Seiko WAM-5500 binocular accommodation auto ref/keratometer | shigiya machinery works LTD.</p><p><strong>Results: </strong>A statistically significant difference was noticed for constriction percentage (%): 32.73 ± 9.20 versus 39.93 ± 7.36 (<i>P</i> < 0.001), average constriction velocity (mm/s): 2.24 ± 0.85 versus 2.62 ± 0.68 (<i>P</i> = 0.002), maximum constriction velocity (mm/s): 3.82 ± 1.33 versus 4.42 ± 0.93 (<i>P</i> = 0.004) and T75 (recovery period to 75% of the baseline pupillary diameter in sec): 1.38 ± 0.36 versus 2.0 ± 0.82 (<i>P</i> < 0.001) in mTBI compared to age-matched controls. A statistically significant difference was noted for accommodative response (in D) as well as in the sample as compared to age-matched controls: -1.12 ± 0.64 versus - 1.39 ± 0.47 (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Pupillary constriction velocities and accommodative response are significantly affected in mTBI. These findings have important clinical implications in being able to understand the visual symptoms following an mTBI.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"248-255"},"PeriodicalIF":1.0,"publicationDate":"2023-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11253999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence and digital solutions for myopia. 人工智能和数字近视解决方案。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-16 eCollection Date: 2023-04-01 DOI: 10.4103/tjo.TJO-D-23-00032
Yong Li, Michelle Y T Yip, Daniel S W Ting, Marcus Ang

Myopia as an uncorrected visual impairment is recognized as a global public health issue with an increasing burden on health-care systems. Moreover, high myopia increases one's risk of developing pathologic myopia, which can lead to irreversible visual impairment. Thus, increased resources are needed for the early identification of complications, timely intervention to prevent myopia progression, and treatment of complications. Emerging artificial intelligence (AI) and digital technologies may have the potential to tackle these unmet needs through automated detection for screening and risk stratification, individualized prediction, and prognostication of myopia progression. AI applications in myopia for children and adults have been developed for the detection, diagnosis, and prediction of progression. Novel AI technologies, including multimodal AI, explainable AI, federated learning, automated machine learning, and blockchain, may further improve prediction performance, safety, accessibility, and also circumvent concerns of explainability. Digital technology advancements include digital therapeutics, self-monitoring devices, virtual reality or augmented reality technology, and wearable devices - which provide possible avenues for monitoring myopia progression and control. However, there are challenges in the implementation of these technologies, which include requirements for specific infrastructure and resources, demonstrating clinically acceptable performance and safety of data management. Nonetheless, this remains an evolving field with the potential to address the growing global burden of myopia.

近视作为一种未矫正的视力损伤,已被公认为是一个全球性的公共卫生问题,对医疗保健系统造成的负担越来越重。此外,高度近视会增加患病理性近视的风险,从而导致不可逆转的视力损伤。因此,需要增加资源来早期识别并发症,及时干预以防止近视发展,并治疗并发症。新兴的人工智能(AI)和数字技术有可能通过自动检测筛查和风险分层、个性化预测以及近视发展的预后来满足这些尚未得到满足的需求。针对儿童和成人近视的人工智能应用已经开发出来,用于检测、诊断和预测近视的发展。新的人工智能技术,包括多模态人工智能、可解释人工智能、联合学习、自动机器学习和区块链,可能会进一步提高预测性能、安全性和可及性,并规避对可解释性的担忧。数字技术的进步包括数字疗法、自我监测设备、虚拟现实或增强现实技术以及可穿戴设备--这些都为监测和控制近视的发展提供了可能的途径。然而,这些技术的实施也面临着挑战,其中包括对特定基础设施和资源的要求、证明临床上可接受的性能以及数据管理的安全性。尽管如此,这仍然是一个不断发展的领域,有可能解决全球日益沉重的近视负担。
{"title":"Artificial intelligence and digital solutions for myopia.","authors":"Yong Li, Michelle Y T Yip, Daniel S W Ting, Marcus Ang","doi":"10.4103/tjo.TJO-D-23-00032","DOIUrl":"10.4103/tjo.TJO-D-23-00032","url":null,"abstract":"<p><p>Myopia as an uncorrected visual impairment is recognized as a global public health issue with an increasing burden on health-care systems. Moreover, high myopia increases one's risk of developing pathologic myopia, which can lead to irreversible visual impairment. Thus, increased resources are needed for the early identification of complications, timely intervention to prevent myopia progression, and treatment of complications. Emerging artificial intelligence (AI) and digital technologies may have the potential to tackle these unmet needs through automated detection for screening and risk stratification, individualized prediction, and prognostication of myopia progression. AI applications in myopia for children and adults have been developed for the detection, diagnosis, and prediction of progression. Novel AI technologies, including multimodal AI, explainable AI, federated learning, automated machine learning, and blockchain, may further improve prediction performance, safety, accessibility, and also circumvent concerns of explainability. Digital technology advancements include digital therapeutics, self-monitoring devices, virtual reality or augmented reality technology, and wearable devices - which provide possible avenues for monitoring myopia progression and control. However, there are challenges in the implementation of these technologies, which include requirements for specific infrastructure and resources, demonstrating clinically acceptable performance and safety of data management. Nonetheless, this remains an evolving field with the potential to address the growing global burden of myopia.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"13 2","pages":"142-150"},"PeriodicalIF":1.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/43/a6/TJO-13-142.PMC10361438.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography and contrast sensitivity in early diabetic retinopathy. 早期糖尿病视网膜病变的光学相干断层扫描和对比敏感度。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2023-05-16 eCollection Date: 2024-07-01 DOI: 10.4103/tjo.TJO-D-22-00108
Hadi Ostadimoghadam, Toktam Helmi, Abbasali Yekta, Javad Heravian Shandiz, Hojat Shafaei, Hamed Momeni Moghadam, Monireh Mahjoob

Purpose: This study used contrast sensitivity (CS) and optical coherence tomography (OCT) to assess the functional and structural alterations of the macula and the optic nerve head (ONH) in diabetic patients with no retinopathy and those with mild nonproliferative diabetic retinopathy (NPDR).

Materials and methods: In this study, 40 eyes of 20 diabetic patients with no diabetic retinopathy (DR), 40 eyes of 20 diabetic patients with mild NPDR, and 36 eyes of 18 healthy individuals were examined. Best-corrected visual acuity (VA) and CS were performed using early treatment DR study charts and the Pelli-Robson chart, respectively. The macula and ONH were evaluated using OCT, which provided data on the entire retina, inner retinal layer, outer retinal layer, retinal nerve fiber layer (RNFL), and the macula zone-ellipsoid zone-retinal pigment epithelium layer.

Results: VA and CS were significantly different between the three groups (P < 0.001). The entire thickness of the retina and the internal thickness of the retina in the 3-6 mm subfields of the macular region, as well as the thickness of the ganglion cell layer + inner plexiform layer (GCL + IPL) and GCL + IPL + RNFLs, differed significantly across the groups (P < 0.013).

Conclusion: In diabetic subjects with no retinopathy, the reduced thickness of the GCL + IPLs is possibly indicative of early neurodegenerative changes in the inner retina. Furthermore, in the diabetic groups, a decrease in CS was observed compared to the control group.

目的:本研究使用对比敏感度(CS)和光学相干断层扫描(OCT)评估无视网膜病变的糖尿病患者和轻度非增殖性糖尿病视网膜病变(NPDR)患者黄斑和视神经头(ONH)的功能和结构改变:在这项研究中,对 20 名无糖尿病视网膜病变(DR)的糖尿病患者的 40 只眼睛、20 名轻度非增殖性糖尿病视网膜病变(NPDR)的糖尿病患者的 40 只眼睛以及 18 名健康人的 36 只眼睛进行了检查。最佳矫正视力(VA)和CS分别使用早期治疗糖尿病视网膜病变研究图表和佩利-罗布森图表进行。使用 OCT 对黄斑和视网膜上皮进行了评估,OCT 提供了整个视网膜、视网膜内层、视网膜外层、视网膜神经纤维层(RNFL)以及黄斑区-椭圆体区-视网膜色素上皮层的数据:三组患者的 VA 和 CS 均有明显差异(P < 0.001)。视网膜的整体厚度和黄斑区 3-6 mm 亚视场的视网膜内部厚度,以及神经节细胞层 + 内丛状层(GCL + IPL)和 GCL + IPL + RNFL 的厚度在各组间存在显著差异(P < 0.013):结论:在无视网膜病变的糖尿病受试者中,GCL + IPL厚度的减少可能表明视网膜内层发生了早期神经退行性病变。此外,与对照组相比,在糖尿病组中观察到 CS 减少。
{"title":"Optical coherence tomography and contrast sensitivity in early diabetic retinopathy.","authors":"Hadi Ostadimoghadam, Toktam Helmi, Abbasali Yekta, Javad Heravian Shandiz, Hojat Shafaei, Hamed Momeni Moghadam, Monireh Mahjoob","doi":"10.4103/tjo.TJO-D-22-00108","DOIUrl":"10.4103/tjo.TJO-D-22-00108","url":null,"abstract":"<p><strong>Purpose: </strong>This study used contrast sensitivity (CS) and optical coherence tomography (OCT) to assess the functional and structural alterations of the macula and the optic nerve head (ONH) in diabetic patients with no retinopathy and those with mild nonproliferative diabetic retinopathy (NPDR).</p><p><strong>Materials and methods: </strong>In this study, 40 eyes of 20 diabetic patients with no diabetic retinopathy (DR), 40 eyes of 20 diabetic patients with mild NPDR, and 36 eyes of 18 healthy individuals were examined. Best-corrected visual acuity (VA) and CS were performed using early treatment DR study charts and the Pelli-Robson chart, respectively. The macula and ONH were evaluated using OCT, which provided data on the entire retina, inner retinal layer, outer retinal layer, retinal nerve fiber layer (RNFL), and the macula zone-ellipsoid zone-retinal pigment epithelium layer.</p><p><strong>Results: </strong>VA and CS were significantly different between the three groups (<i>P</i> < 0.001). The entire thickness of the retina and the internal thickness of the retina in the 3-6 mm subfields of the macular region, as well as the thickness of the ganglion cell layer + inner plexiform layer (GCL + IPL) and GCL + IPL + RNFLs, differed significantly across the groups (<i>P</i> < 0.013).</p><p><strong>Conclusion: </strong>In diabetic subjects with no retinopathy, the reduced thickness of the GCL + IPLs is possibly indicative of early neurodegenerative changes in the inner retina. Furthermore, in the diabetic groups, a decrease in CS was observed compared to the control group.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":"1 1","pages":"403-408"},"PeriodicalIF":1.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70847165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Taiwan Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1